Cargando…
CAR-T细胞桥接异基因造血干细胞移植治疗复发/难治急性B淋巴细胞白血病的临床分析
OBJECTIVE: This study aims to investigate the efficacy and safety of chimeric antigen receptor（CAR）T-cell bridging allogeneic hematopoietic stem cell transplantation（allo-HSCT）in the treatment of recurrent and refractory acute B-lymphocytic leukemia（R/R B-ALL）. METHODS: A total of 50 R/R B-ALL patie...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595870/ https://www.ncbi.nlm.nih.gov/pubmed/33113601 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.002 |